Entering text into the input field will update the search result below

ONXX Did Not Suffer A Trial Failure

Jul. 25, 2012 2:33 AM ETONXX
Juuso E profile picture
Juuso E's Blog
3 Followers
Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

It's outrageous that the more or less popular sites such as Wall Street Cheat Sheet do not excercise more care when choosing a title for their articles -

Title: "Cancer drug Nexavar from Bayer and Onyx fails in a late-stage combo trial"

The reality of the situation, quoted from the Article:

"Nexavar treatment for liver cancer, which is made jointly by Onyx Pharmaceuticals, Inc. (NASDAQ:ONXX) and Bayer A.G.(OTCPK:BAYZF), was used in combination with Tarceva, but the pairing failed to improve survival rates compared with Nexavar on its own in a Phase III trial."

Nexavar + Tarceva = Nexavar, how'd Nexavar fail?

Disclosure: I am long ONXX.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You